This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Harness New Scientific Development, Technological Innovation and Operational Advances To Accelerate Through Phase I and IIa Clinical Trials

Explore The Opportunities With Early Phase Clinical Case Studies, Regulatory Guidance And Interactive Panel Discussions

Pave The Path To Proof Of Concept With An Ascending Dose Of Efficiency

Key early phase regulatory insights
  • Benefit from the latest updates and insights from leading European regulators
  • Get up to speed: clinical trial regulations 2020; FIH guidance update and new cardiac safety assessments
  • Understand the regulatory approach to innovative protocol designs in early phase designs

Pioneering science to accelerate the early clinical process
  • Hear from 10+ leading pharmaceutical and biotech professionals
  • Discover how to deliver a well-designed ECD plan to get your product onto the market faster
  • Benefit from a showcase of innovation: case study insights from trailblazers

Operational strategies for Phase I and IIa clinical studies revealed
  • How are innovative Phase I and IIa clinical studies run? Get top tips...
  • Partnerships: Reach Proof of Concept faster through effective collaboration
  • Harness the power of the patient: talking patient-centricity, recruitment and safety

Sponsorship & Exhibition Opportunities

To discuss how your company can get involved, please contact Dylan Smith:

+44 20 3377 3237

Associate Sponsors